Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.

Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Ekström Smedby K, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjosé S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay JD, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Wong Doo N, Giles GG, Southey MC, Milne RL, Offit K, Muskinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Boffetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF.

Cancer Res. 2018 May 7. pii: canres.2900.2017. doi: 10.1158/0008-5472.CAN-17-2900. [Epub ahead of print]

PMID:
29735552
2.

Ethnic disparity in primary cutaneous CD30+ T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer database.

Feldman AL, Flowers CR.

Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15221. [Epub ahead of print] No abstract available.

PMID:
29676455
3.

Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.

Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, Glaser SL, Wun T.

Cancer Causes Control. 2018 Jun;29(6):551-561. doi: 10.1007/s10552-018-1025-0. Epub 2018 Apr 13.

PMID:
29654427
4.

Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.

Link BK, Day BM, Zhou X, Zelenetz AD, Dawson KL, Cerhan JR, Flowers CR, Friedberg JW.

Br J Haematol. 2018 Apr 2. doi: 10.1111/bjh.15149. [Epub ahead of print] No abstract available.

PMID:
29611177
5.

Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation.

Becnel M, Flowers CR, Nastoupil LJ.

Ann Lymphoma. 2017 Nov;1. pii: 8. doi: 10.21037/aol.2017.11.01. Epub 2017 Nov 17.

6.

Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab.

Croteau D, Flowers C, Kulick CG, Brinker A, Kortepeter CM.

Neurology. 2018 May 1;90(18):e1548-e1552. doi: 10.1212/WNL.0000000000005422. Epub 2018 Mar 30.

PMID:
29602912
7.

Impact of the posttransplant lymphoproliferative disorder subtype on survival.

Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK.

Cancer. 2018 Mar 26. doi: 10.1002/cncr.31339. [Epub ahead of print]

PMID:
29579330
8.

Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.

Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowers CR, Cohen JB.

Cancer. 2018 Mar 26. doi: 10.1002/cncr.31328. [Epub ahead of print]

PMID:
29579328
9.

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.

Taplitz RA, Kennedy EB, Flowers CR.

J Oncol Pract. 2018 Apr;14(4):250-255. doi: 10.1200/JOP.18.00016. Epub 2018 Mar 8. No abstract available.

PMID:
29517953
10.

Balancing patient value and payer cost in hematologic malignancies: can it be done?

Allen PB, Flowers CR.

Expert Rev Pharmacoecon Outcomes Res. 2018 Apr;18(2):123-126. doi: 10.1080/14737167.2018.1444478. Epub 2018 Mar 13. No abstract available.

PMID:
29486601
11.

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR.

J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.

PMID:
29461916
12.

3D 7Li magnetic resonance imaging of brain lithium distribution in bipolar disorder.

Smith FE, Thelwall PE, Necus J, Flowers CJ, Blamire AM, Cousins DA.

Mol Psychiatry. 2018 Feb 9. doi: 10.1038/s41380-018-0016-6. [Epub ahead of print]

PMID:
29426954
13.

Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study.

Flowers CR, Nabhan C, Kay NE, Mato A, Lamanna N, Farber CM, Davids MS, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP.

Leuk Lymphoma. 2018 Feb 7:1-9. doi: 10.1080/10428194.2018.1427860. [Epub ahead of print]

PMID:
29415595
14.

Comparison of Resting Energy Expenditure Assessment in Pediatric Oncology Patients.

Ringwald-Smith K, Hobar A, Flowers C, Badgett K, Williams-Hooker R, Roach RR, Sykes A, Lu Z, Mackert P, Mandrell BN.

Nutr Clin Pract. 2018 Apr;33(2):224-231. doi: 10.1002/ncp.10002. Epub 2018 Feb 2.

PMID:
29393551
15.

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.

Petersen CT, Hassan M, Morris AB, Jeffery J, Lee K, Jagirdar N, Staton AD, Raikar SS, Spencer HT, Sulchek T, Flowers CR, Waller EK.

Blood Adv. 2018 Feb 13;2(3):210-223. doi: 10.1182/bloodadvances.2017011254.

16.

Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.

Mato A, Nabhan C, Kay NE, Lamanna N, Kipps TJ, Grinblatt DL, Flowers CR, Farber CM, Davids MS, Kiselev P, Swern AS, Bhushan S, Sullivan K, Flick ED, Sharman JP.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):114-124.e2. doi: 10.1016/j.clml.2017.11.010. Epub 2017 Dec 6.

17.

Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.

Ahn IE, Farber CM, Davids MS, Grinblatt DL, Kay NE, Lamanna N, Mato A, Nabhan C, Kiselev P, Swern AS, Flick ED, Sullivan K, Sharman JP, Flowers CR.

Blood Adv. 2017 Nov 28;1(25):2433-2443. doi: 10.1182/bloodadvances.2017011262. eCollection 2017 Nov 28.

18.

Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.

Koff JL, Rai A, Flowers CR.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):e115-e121. doi: 10.1016/j.clml.2017.11.009. Epub 2017 Dec 2.

PMID:
29273217
19.

Effective management strategies for patients with marginal zone lymphoma.

Rosand CB, Valla K, Flowers CR, Koff JL.

Future Oncol. 2017 Dec 20. doi: 10.2217/fon-2017-0480. [Epub ahead of print]

PMID:
29260925
20.

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.

Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M.

Biol Blood Marrow Transplant. 2017 Dec 11. pii: S1083-8791(17)31675-0. doi: 10.1016/j.bbmt.2017.12.771. [Epub ahead of print]

PMID:
29242111
21.

When to Choose Transplant in Follicular Lymphoma: Navigating a Complex Landscape.

Casulo C, Flowers CR.

J Oncol Pract. 2017 Dec;13(12):808-809. doi: 10.1200/JOP.2017.028340. No abstract available.

PMID:
29232538
22.

Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.

Chang A, Schlafer D, Flowers CR, Allen PB.

Expert Opin Investig Drugs. 2018 Jan;27(1):55-70. doi: 10.1080/13543784.2018.1416091. Epub 2017 Dec 24. Review.

PMID:
29228840
23.

How are perceptions associated with water consumption in Canadian Inuit? A cross-sectional survey in Rigolet, Labrador.

Wright CJ, Sargeant JM, Edge VL, Ford JD, Farahbakhsh K, Shiwak I, Flowers C, Gordon AC; RICG; IHACC Research Team, Harper SL.

Sci Total Environ. 2018 Mar 15;618:369-378. doi: 10.1016/j.scitotenv.2017.10.255. Epub 2017 Nov 10.

PMID:
29132004
24.

Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.

Chen Q, Staton AD, Ayer T, Goldstein DA, Koff JL, Flowers CR.

Leuk Lymphoma. 2017 Oct 25:1-10. doi: 10.1080/10428194.2017.1390230. [Epub ahead of print]

PMID:
29065744
25.

Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama.

McKenna ML, McAtee S, Bryan PE, Jeun R, Ward T, Kraus J, Bottazzi ME, Hotez PJ, Flowers CC, Mejia R.

Am J Trop Med Hyg. 2017 Nov;97(5):1623-1628. doi: 10.4269/ajtmh.17-0396. Epub 2017 Oct 10.

26.

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.

Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.

PMID:
28985567
27.

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S.

J Clin Oncol. 2017 Nov 1;35(31):3538-3546. doi: 10.1200/JCO.2017.73.2784. Epub 2017 Sep 1.

PMID:
28862883
28.

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

Lin RJ, Behera M, Diefenbach CS, Flowers CR.

Blood. 2017 Nov 16;130(20):2180-2185. doi: 10.1182/blood-2017-05-736975. Epub 2017 Aug 16. Review. Erratum in: Blood. 2018 Mar 1;131(9):1037.

PMID:
28814386
29.

The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.

Sargent DJ, Shi Q, Flowers CR, Schmitz N, Habermann TM, Flament J, Fu T, Coiffier B; SEAL group.

Oncologist. 2017 Dec;22(12):1415-1418. doi: 10.1634/theoncologist.2017-0177. Epub 2017 Aug 10. No abstract available.

30.

Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.

Guidot DM, Switchenko JM, Nastoupil LJ, Koff JL, Blum KA, Maly J, Flowers CR, Cohen JB.

Leuk Lymphoma. 2018 Apr;59(4):888-895. doi: 10.1080/10428194.2017.1361032. Epub 2017 Aug 10.

PMID:
28797213
31.

The importance of immunization in cancer prevention, treatment, and survivorship.

Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA.

CA Cancer J Clin. 2017 Sep;67(5):398-410. doi: 10.3322/caac.21407. Epub 2017 Jul 28. Review.

32.

C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.

Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ.

Cancer. 2017 Nov 15;123(22):4411-4418. doi: 10.1002/cncr.30895. Epub 2017 Jul 27. Erratum in: Cancer. 2018 Feb 15;124(4):867.

PMID:
28749548
33.

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

Cancer Res. 2017 Sep 1;77(17):4548-4555. doi: 10.1158/0008-5472.CAN-17-0623. Epub 2017 Jul 24. No abstract available.

PMID:
28739629
34.

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

CA Cancer J Clin. 2017 Sep;67(5):353-361. doi: 10.3322/caac.21404. Epub 2017 Jul 24. No abstract available.

35.

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

J Clin Oncol. 2017 Sep 10;35(26):3075-3082. doi: 10.1200/JCO.2017.73.6546. Epub 2017 Jul 24. No abstract available.

PMID:
28737975
36.

Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma.

Zeichner SB, Goldstein DA, Kohn C, Flowers CR.

J Gastrointest Oncol. 2017 Jun;8(3):513-523. doi: 10.21037/jgo.2016.04.03. Review.

37.

Reply to Á. Benedict et al.

Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR.

J Clin Oncol. 2017 Sep 10;35(26):3086-3087. doi: 10.1200/JCO.2017.74.5273. Epub 2017 Jul 17. No abstract available.

PMID:
28715248
38.

Water quality and health in northern Canada: stored drinking water and acute gastrointestinal illness in Labrador Inuit.

Wright CJ, Sargeant JM, Edge VL, Ford JD, Farahbakhsh K; RICG, Shiwak I, Flowers C; IHACC Research Team, Harper SL.

Environ Sci Pollut Res Int. 2017 Jul 12. doi: 10.1007/s11356-017-9695-9. [Epub ahead of print]

PMID:
28702908
39.

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.

Goldstein DA, Chen Q, Ayer T, Chan KKW, Virik K, Hammerman A, Brenner B, Flowers CR, Hall PS.

Oncologist. 2017 Jun;22(6):694-699. doi: 10.1634/theoncologist.2016-0455. Epub 2017 Jun 7.

PMID:
28592621
40.

Making the Case for Improving Oncology Workforce Diversity.

Winkfield KM, Flowers CR, Mitchell EP.

Am Soc Clin Oncol Educ Book. 2017;37:18-22. doi: 10.14694/EDBK_100010. No abstract available.

41.

Reply to C. Nabhan et al.

Chen Q, Jain N, Flowers CR, Chhatwal J.

J Clin Oncol. 2017 Jun 1;35(16):1864-1865. doi: 10.1200/JCO.2017.72.2769. Epub 2017 Mar 13. No abstract available.

PMID:
28549223
42.

Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.

Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM.

Br J Haematol. 2017 Jul;178(1):72-80. doi: 10.1111/bjh.14638. Epub 2017 May 25.

43.

Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?

Koff JL, Flowers CR.

Cancer. 2017 Sep 1;123(17):3222-3225. doi: 10.1002/cncr.30740. Epub 2017 May 2. No abstract available.

PMID:
28464215
44.

American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce.

Winkfield KM, Flowers CR, Patel JD, Rodriguez G, Robinson P, Agarwal A, Pierce L, Brawley OW, Mitchell EP, Head-Smith KT, Wollins DS, Hayes DF.

J Clin Oncol. 2017 Aug 1;35(22):2576-2579. doi: 10.1200/JCO.2017.73.1372. Epub 2017 May 1.

PMID:
28459634
45.

Unmet needs in the first-line treatment of follicular lymphoma.

Casulo C, Nastoupil L, Fowler NH, Friedberg JW, Flowers CR.

Ann Oncol. 2017 Sep 1;28(9):2094-2106. doi: 10.1093/annonc/mdx189. Review.

PMID:
28430865
46.

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.

Hamilton BK, Rybicki L, Abounader D, Adekola K, Advani A, Aldoss I, Bachanova V, Bashey A, Brown S, DeLima M, Devine S, Flowers CR, Ganguly S, Jagasia M, Kennedy VE, Kim DDH, McGuirk J, Pullarkat V, Romee R, Sandhu K, Smith M, Ueda M, Viswabandya A, Vu K, Wall S, Zeichner SB, Perales MA, Majhail NS.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1117-1121. doi: 10.1016/j.bbmt.2017.04.003. Epub 2017 Apr 7.

47.

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.

Guo X, Koff JL, Moffitt AB, Cinar M, Ramachandiran S, Chen Z, Switchenko JM, Mosunjac M, Neill SG, Mann KP, Bagirov M, Du Y, Natkunam Y, Khoury HJ, Rossi MR, Harris W, Flowers CR, Lossos IS, Boise LH, Dave SS, Kowalski J, Bernal-Mizrachi L.

Oncogene. 2017 Jul 20;36(29):4224-4232. doi: 10.1038/onc.2017.90. Epub 2017 Apr 3.

PMID:
28368397
48.

Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.

Shah NN, McClellan W, Flowers CR, Lonial S, Khoury H, Waller EK, Langston A, Nooka AK.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):651-657. doi: 10.1017/ice.2017.12. Epub 2017 Mar 23.

PMID:
28330512
49.

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.

Gopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW.

Blood. 2017 Jun 1;129(22):3037-3039. doi: 10.1182/blood-2016-12-757740. Epub 2017 Mar 21. No abstract available.

PMID:
28325864
50.

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.

Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP.

BMC Cancer. 2017 Mar 16;17(1):198. doi: 10.1186/s12885-017-3176-x.

Supplemental Content

Loading ...
Support Center